- Home
- Featured Publications
- Center Publications
- Harnessing reaction-based probes to preferentially target pancreatic β-cells and β-like cells.
Harnessing reaction-based probes to preferentially target pancreatic β-cells and β-like cells.
Citation | “Harnessing Reaction-Based Probes To Preferentially Target Pancreatic Β-Cells And Β-Like Cells.”. Life Science Alliance. . |
Center | Joslin Diabetes Center |
Author | Sevim Kahraman, Debasish Manna, Ercument Dirice, Basudeb Maji, Jonnell Small, Bridget K Wagner, Amit Choudhary, Rohit N Kulkarni |
Abstract |
Highly sensitive approaches to target insulin-expressing cells would allow more effective imaging, sorting, and analysis of pancreatic β-cells. Here, we introduce the use of a reaction-based probe, diacetylated Zinpyr1 (DA-ZP1), to image pancreatic β-cells and β-like cells derived from human pluripotent stem cells. We harness the high intracellular zinc concentration of β-cells to induce a fluorescence signal in cells after administration of DA-ZP1. Given its specificity and rapid uptake by cells, we used DA-ZP1 to purify live stem cell-derived β-like cells as confirmed by immunostaining analysis. We tested the ability of DA-ZP1 to image transplanted human islet grafts and endogenous mouse pancreatic islets in vivo after its systemic administration into mice. Thus, DA-ZP1 enables purification of insulin-secreting β-like cells for downstream applications, such as functional studies, gene-expression, and cell-cell interaction analyses and can be used to label engrafted human islets and endogenous mouse islets in vivo. |
Year of Publication |
2021
|
Journal |
Life science alliance
|
Volume |
4
|
Issue |
4
|
Date Published |
12/2021
|
ISSN Number |
2575-1077
|
DOI |
10.26508/lsa.202000840
|
Alternate Journal |
Life Sci Alliance
|
PMID |
33514654
|
PMCID |
PMC7898467
|
Download citation |